ArticlePloS one2024

Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer.

Ravi K Anchoori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.